Share

April 19, 2016; 86 (16) Article

Medicare Part D payments for neurologist-prescribed drugs

Lindsey B. De Lott, James F. Burke, Kevin A. Kerber, Lesli E. Skolarus, Brian C. Callaghan
First published March 23, 2016, DOI: https://doi.org/10.1212/WNL.0000000000002589
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
263

Share

Article Information

vol. 86 no. 16 1491-1498
DOI: 
https://doi.org/10.1212/WNL.0000000000002589
PubMed: 
27009256
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received August 18, 2015
  • Accepted in final form January 7, 2016
  • First Published March 23, 2016.

Article Versions

Copyright & Usage: 
© 2016 American Academy of Neurology

Author Disclosures

    1. Lindsey B. De Lott, MD, MS,
    2. James F. Burke, MD, MS,
    3. Kevin A. Kerber, MD, MS,
    4. Lesli E. Skolarus, MD, MS and
    5. Brian C. Callaghan, MD, MS
  1. Lindsey B. De Lott, MD, MS,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH 5T32NS7222-32, trainee, 2 years

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. James F. Burke, MD, MS,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. American Academy of Neurology, Continuum Article

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Dr. Burke has received compensation from Astra Zeneca for his role as an adjudicator in the SOCRATES trial.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Dr. Burke is funded by NIH K08 NS082597 and R01 MD008879.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Dr. Burke has reviewed case materials in a medical malpractice defense case.

  3. Kevin A. Kerber, MD, MS,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Elsevier Inc, author honoraria (2) American Academy of Neurology, travel funding

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Clinical Neurophysiology of the Vestibular System, 4th edition, Oxford University Press, 2011

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) American Academy of Neurology (2) University of California San Francisco (including work on a project funded by AstraZeneca) (3) Best Doctors, Inc

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. (1) NIH, loan repayment award. (2) American Academy of Neurology, speaker honoraria (3) University of Southern California, speaker honoraria (4) University of Illinois College of Medicine at Peoria, speaker honoraria and travel funding

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH/NIDCD R01DC012760, principal investigator, 2013-2018 (2) AHRQ R18HS022258, principal investigator, 2014-2019 (3) AHRQ R18 HS017690, principal investigator, 2009-2013 (4) NIH U01DC013778-01A1, site investigator, 2014-2019

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. (1) Phil Pearsons, MD, JD., review of legal records, 2013 (2) National Medical Consultants, review of legal records, 2014

  4. Lesli E. Skolarus, MD, MS and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Travel to ANA/NINDS K23 conference via ANA/NINDS

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH NINDS K23NS073685, R01MD008879, R21NS084081

    Research Support, Academic Entities:

    1. Receives institutional support from the University of Michigan for stroke-related research projects. Blue Cross Blue Shield of Michigan Foundation

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Brian C. Callaghan, MD, MS
    6. Scientific Advisory Boards:

    1. Consultant and scientific advisory board member on a PCORI grant

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1) American Academy of Neurology, travel 2) World Federation of Neurology, travel

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultant and scientific advisory board member on a PCORI grant

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. 1. ALS Association, certify centers 2. Advance Medical, patient consultation service 3. Honoraria from the British Medical Journal

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Impeto Medical Inc.

    Research Support, Government Entities:

    1. NIH K23 NS079417-01, PI, 5 year award

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Consultant for medical legal case

  1. From the Department of Neurology, University of Michigan, Ann Arbor.
  1. Correspondence to Dr. De Lott: ldelott{at}med.umich.edu
View Full Text

Article usage

Article usage: March 2016 to July 2022

AbstractFullPdfSource
Mar 2016318013Highwire
Apr 201613871431Highwire
May 20164731429Highwire
Jun 201617702Highwire
Jul 201611111Highwire
Aug 20168730Highwire
Sep 20169134Highwire
Oct 20168934Highwire
Nov 20166202Highwire
Dec 20167901Highwire
Jan 20178833Highwire
Feb 20175132Highwire
Mar 20176712Highwire
Apr 20176133Highwire
Apr 2017176pmc
May 20177213Highwire
May 201761413pmc
Jun 20174511Highwire
Jun 2017479pmc
Jul 20173500Highwire
Jul 2017176pmc
Aug 20171810Highwire
Aug 2017233pmc
Sep 20171600Highwire
Sep 2017354pmc
Oct 20173224Highwire
Oct 2017254pmc
Nov 20173201Highwire
Nov 201731214pmc
Dec 20171420Highwire
Jan 20181000Highwire
Feb 201813811Highwire
Mar 20182100Highwire
Apr 20181610Highwire
Apr 201831921pmc
May 20181201Highwire
Jun 20181400Highwire
Jun 201831723pmc
Jul 20182011Highwire
Aug 2018401Highwire
Aug 201821717pmc
Sep 2018533Highwire
Oct 20181831Highwire
Nov 20181900Highwire
Dec 20181400Highwire
Jan 2019300Highwire
Feb 2019801Highwire
Mar 2019800Highwire
Apr 2019810Highwire
May 20199031Highwire
Jun 20191030Highwire
Jul 20191421Highwire
Aug 20192933Highwire
Sep 2019600Highwire
Oct 20191601Highwire
Nov 20191831Highwire
Dec 20191001Highwire
Jan 20202001Highwire
Feb 20201100Highwire
Mar 20201801Highwire
Apr 20202211Highwire
May 20202411Highwire
Jun 2020500Highwire
Jul 20201211Highwire
Aug 20201000Highwire
Sep 20201800Highwire
Oct 20202211Highwire
Nov 20202910Highwire
Dec 20201611Highwire
Jan 20211442Highwire
Feb 20212523Highwire
Mar 20213100Highwire
Apr 20213101Highwire
May 20212950Highwire
Jun 20212510Highwire
Jul 20213010Highwire
Aug 20212520Highwire
Sep 20211500Highwire
Oct 20212311Highwire
Nov 20213110Highwire
Dec 20211300Highwire
Jan 20222901Highwire
Feb 20222400Highwire
Mar 20223810Highwire
Apr 20222602Highwire
May 20222321Highwire
Jun 20228100Highwire
Jul 20223702Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me